• Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder
  • Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder
  • Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder
  • Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder
  • Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder

Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder

Powder: Yes
Customized: Non-Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
Purity: >99%
Transport Package: Aluminium Foil Bag, Cardboard Drum
Samples:
US$ 35/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory

Basic Info.

Model NO.
HNB-0078
Trademark
HNB-Biotech
Origin
Shaanxi, China
Production Capacity
5000kg/Month

Product Description

Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder

Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder
Product name Diclofenac sodium
Cas No. 15307-79-6
Molecular Formula C14H10Cl2NNaO2
Appearance White crystalline powder
 
Diclofenac sodium has a effect on anti-inflammatory, analgesic and antipyretic.Diclofenac Sodium is the salt form of diclofenac, an active metabolite of the NSAID aceclofenac (sc-217557). Hydrolysis of aceclofenac, an inhibitor of interleukin-1B-induced prostaglandin E2 production with no inhibitory activity against Cox (cyclooxygenase), generates diclofenac, an inhibitor of both Cox-1 and Cox-2. Oxidation of diclofenac produces the metabolite 4'-hydroxy diclofenac (sc-202423) which demonstrates specific inhibition of Cox-2. Inhibition of Cox by diclofenac and 4'-hydroxy diclofenac suppresses prostaglandin E2 synthesis, producing antiinflammatory and analgesic effects. Diclofenac is also shown to stabilize the native tetrameric conformation of transthyretin (TTR) fibrils, preventing the formation of insolubleamyloidogenic TTR deposits. Diclofenac Sodium is a substrate of CYP2C9.Pharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium PowderPharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium PowderPharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium PowderPharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium PowderPharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium PowderPharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium PowderPharmaceutical Raw Material CAS 15307-79-6 Diclofenac Sodium Powder
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory
Registered Capital
10000000 RMB
Plant Area
101~500 square meters